AG
BPMC
Artal Group’s Blueprint Medicines BPMC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-100,000
| Closed | -$10.3M | – | 149 |
|
|
2021
Q3 | $10.3M | Hold |
100,000
| – | – | 0.23% | 74 |
|
|
2021
Q2 | $8.8M | Buy |
+100,000
| New | +$8.8M | 0.18% | 86 |
|
|
2020
Q3 | – | Sell |
-550,000
| Closed | -$42.9M | – | 130 |
|
|
2020
Q2 | $42.9M | Buy |
550,000
+150,000
| +38% | +$11.7M | 1.2% | 18 |
|
|
2020
Q1 | $23.4M | Hold |
400,000
| – | – | 0.99% | 22 |
|
|
2019
Q4 | $32M | Sell |
400,000
-200,000
| -33% | -$16M | 1.24% | 15 |
|
|
2019
Q3 | $44.1M | Sell |
600,000
-150,000
| -20% | -$11M | 1.77% | 10 |
|
|
2019
Q2 | $70.7M | Sell |
750,000
-100,000
| -12% | -$9.43M | 2.86% | 6 |
|
|
2019
Q1 | $68M | Buy |
850,000
+250,000
| +42% | +$20M | 2.78% | 8 |
|
|
2018
Q4 | $32.3M | Buy |
600,000
+100,000
| +20% | +$5.39M | 1.2% | 13 |
|
|
2018
Q3 | $39M | Sell |
500,000
-200,000
| -29% | -$15.6M | 1.02% | 11 |
|
|
2018
Q2 | $44.4M | Buy |
700,000
+250,000
| +56% | +$15.9M | 0.94% | 7 |
|
|
2018
Q1 | $41.3M | Buy |
450,000
+350,000
| +350% | +$32.1M | 0.52% | 8 |
|
|
2017
Q4 | $7.54M | Buy |
+100,000
| New | +$7.54M | 0.11% | 28 |
|